Priznao sam Sjeveroistok fontana nature medicine crispr počiniti opis dodatak
Controlling and enhancing CRISPR systems | Nature Chemical Biology
Long-term evaluation of AAV-CRISPR genome editing for Duchenne muscular dystrophy | Nature Medicine
CRISPR-engineered T cells in patients with refractory cancer | Science
Nature Outlook: Genome editing
Nature Medicine on Twitter: "#CRISPR–Cas9-induced DNA damage triggers p53 to limit the efficiency of #geneediting in immortalized human retinal pigment epithelial cells: https://t.co/Ofc8akirQF… https://t.co/jA1qViiOE7"
p53 inhibits CRISPR–Cas9 engineering in human pluripotent stem cells | Nature Medicine
CRISPR–Cas: a tool for cancer research and therapeutics | Nature Reviews Clinical Oncology
The kill-switch for CRISPR that could make gene-editing safer
First CRISPR editing trial results assuage safety concerns
CRISPR algorithm predicts how well gene editing will work - Scope
How CRISPR Is Changing Cancer Research and Treatment - National Cancer Institute
5 Big Mysteries about CRISPR's Origins - Scientific American
Precision CRISPR system averts hearing loss in mice - Boston Children's Discoveries
Nature journal retracts controversial CRISPR paper after authors admit results may be wrong – Retraction Watch
A CRISPR Approach to Treating Sickle Cell – NIH Director's Blog
Single-dose CRISPR-Cas9 therapy extends lifespan of mice with Hutchinson-Gilford progeria syndrome.,Nature Medicine - X-MOL
The new frontier of genome engineering with CRISPR-Cas9 | Science
How CRISPR Is Changing Cancer Research and Treatment - National Cancer Institute
CRISPR: Gene editing and beyond - YouTube
Nature Medicine on Twitter: "Two studies find that #AAV-mediated #CRISPR/ Cas9 therapy extends life span and ameliorates disease-related phenotypes in a mouse model of #progeria. https://t.co/2LfOogSXLX and https://t.co/y5KjuD5Yjb… https://t.co/RMaa25wQoI"
PDF) Systemic nanoparticle delivery of CRISPR-Cas9 ribonucleoproteins for effective tissue specific genome editing
Highly efficient therapeutic gene editing of human hematopoietic stem cells | Nature Medicine